PIGF expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.82379999570071E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.045250E-04 |
Normal-vs-Stage2 |
6.784200E-03 |
Normal-vs-Stage3 |
2.17959994497363E-09 |
Normal-vs-Stage4 |
5.36949995577629E-09 |
Stage1-vs-Stage2 |
7.175400E-01 |
Stage1-vs-Stage3 |
6.34600000000152E-05 |
Stage1-vs-Stage4 |
5.609800E-04 |
Stage2-vs-Stage3 |
4.252100E-02 |
Stage2-vs-Stage4 |
8.072300E-02 |
Stage3-vs-Stage4 |
8.771200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.42600000030413E-07 |
Normal-vs-AfricanAmerican |
3.71049999999817E-05 |
Normal-vs-Asian |
2.134200E-01 |
Caucasian-vs-AfricanAmerican |
8.592200E-01 |
Caucasian-vs-Asian |
5.542600E-01 |
AfricanAmerican-vs-Asian |
4.627400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.35470001672422E-09 |
Normal-vs-Female |
2.615000E-04 |
Male-vs-Female |
2.169600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.30149999999041E-05 |
Normal-vs-Age(41-60Yrs) |
2.59020000004107E-07 |
Normal-vs-Age(61-80Yrs) |
4.13460000003862E-06 |
Normal-vs-Age(81-100Yrs) |
1.110480E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.134800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.121020E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.940600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.148800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.874800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.529800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.946200E-02 |
Normal-vs-Grade 2 |
4.776400E-03 |
Normal-vs-Grade 3 |
2.34139996280192E-09 |
Normal-vs-Grade 4 |
1.92734717074927E-12 |
Grade 1-vs-Grade 2 |
9.796400E-01 |
Grade 1-vs-Grade 3 |
1.935620E-02 |
Grade 1-vs-Grade 4 |
1.098830E-03 |
Grade 2-vs-Grade 3 |
9.93649999999624E-05 |
Grade 2-vs-Grade 4 |
5.64470026276354E-10 |
Grade 3-vs-Grade 4 |
2.082800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.470090E-02 |
Normal-vs-ccB subtype |
1.94190219460211E-11 |
ccA subtype-vs-ccB subtype |
7.31030014300416E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.4071999999451E-06 |
Normal-vs-N1 |
8.976200E-04 |
N0-vs-N1 |
3.243000E-01 |
|
|